Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

HealthTronics Primes Prostate Therapy Business With $146 Mil. Merger

This article was originally published in The Gray Sheet

Executive Summary

HealthTronics' nascent prostate disease segment will be fortified by the addition of Prime Medical's urology customer base, following a planned merger of the firms

You may also be interested in...



Prostate Cancer Diagnosis, Uro-Pathology Services Seeded By HealthTronics

HealthTronics' access to an enhanced physician-customer base, via its purchase of Prime Medical, will help the firm add diagnostics to its core urology offerings next year

Prostate Cancer Diagnosis, Uro-Pathology Services Seeded By HealthTronics

HealthTronics' access to an enhanced physician-customer base, via its purchase of Prime Medical, will help the firm add diagnostics to its core urology offerings next year

Prime Medical Aims For Lithotripsy Vertical Integration Via Medstone Merger

Prime Medical Services will combine its lithotripsy services business with Medstone's and vertically integrate manufacturing operations under a $19 mil. stock swap

Related Content

UsernamePublicRestriction

Register

MT020432

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel